针刺睛明穴(BL1)对比人工泪液治疗中重度干眼症的随机对照试验
在中国2家医院开展的随机临床试验,将120例中重度干眼症患者等分为针刺组与人工泪液组,干预8周并随访24周。第8周时针刺组Schirmer-I试验较基线平均变化为5.75(2.53-9.75),人工泪液组为0.52(-1.18-2.46),组间差5.23(P<0.05);OSDI评分变化组间差8.49(P<0.05);症状NRS、TBUT、CFS变化组间无显著差异;5例发生针刺相关不良事件。结论认为针刺BL1显著促进泪液分泌,对中重度干眼症获益优于人工泪液,但研究结果需进一步验证。
要点
- 针刺睛明穴第8周Schirmer-I试验较基线变化5.75,人工泪液组0.52,组间差5.23(P<0.05)。
- OSDI评分变化组间差8.49(P<0.05),针刺组优于人工泪液组。
- 症状NRS、TBUT、CFS变化组间无显著差异;5例发生针刺相关不良事件。
核心结论
- 针刺BL1显著促进泪液分泌,对中重度干眼症的获益优于人工泪液,但研究结果需进一步验证。
研究设计与样本
- 在中国2家医院开展的随机临床试验,120例干眼症患者随机等分为针刺组与人工泪液组,干预8周并随访24周。
主要发现
- 第8周Schirmer-I试验较基线平均变化针刺组5.75(2.53-9.75),人工泪液组0.52(-1.18-2.46),组间差5.23(P<0.05)。
- 第8周OSDI评分较基线变化组间差8.49(P<0.05)。
- 第8周症状NRS平均评分、TBUT、CFS变化组间无显著差异。
- 5例发生针刺相关不良事件。
局限性
- 原文结论指出研究结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The global incidence of dry eye disease (DED) is very high. DED seriously affects the quality of life of patients; however, the current curative effect of medicine for moderate to severe DED is poor. This randomized clinical trial was planned to investigate the effect of acupuncture compared with artificial tears (AT) on moderate to severe DED. METHODS: A randomized clinical trial was performed at 2 hospitals in China. 120 DED patients were randomly equally divided into an acupuncture and an artificial tear group. Either acupuncture or artificial tears was performed for an 8-week period, and a 24-week follow-up was performed. The primary outcome measure was the Schirmer-I test (SIT) change from baseline. The secondary outcome measures included the numerical rating scale (NRS) change from baseline for improvement in ocular symptoms, the ocular surface disease index (OSDI), the tear-film break-up time (TBUT), corneal fluorescein staining (CFS), and acupuncture acceptability. Adverse events also were monitored and documented. RESULTS: For the primary outcome, the mean changes from baseline in the SIT values were significantly different between the acupuncture (5.75 [2.53-9.75]) and AT (0.52 [- 1.18-2.46]) groups at week 8 with a between difference of 5.23 (P < 0.05). Between-group differences of 8.49 in OSDI score change from baseline differed significantly at week 8 (P < 0.05). However, between-group differences of the changes in the average symptom NRS score, TBUT, and CFS did not differ significantly at week 8. Five cases experienced acupuncture-related adverse events. CONCLUSIONS: This randomized clinical trial found that acupuncture at BL1 significantly promoted tear secretion. Acupuncture showed greater benefits than AT for moderate to severe DED. However, the study findings warrant verification. TRIAL REGISTRATION: Registration number: ChiCTR1800015831. Name of trial registry: Efficacy and safety of acupuncture in the treatment of moderate to severe dry eye disease: a randomized controlled trial. Registered on 23 April 2018 ( https://clinicaltrials.gov/ ).
引用
- Zhang X, Zhang B, Peng S, et al. Effectiveness of acupuncture at acupoint BL1 (Jingming) in comparison with artificial tears for moderate to severe dry eye disease: a randomized controlled trial. Trials. 2022. PMID: 35897025. doi:10.1186/s13063-022-06486-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。